Corrigendum to “Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes” [Eur. Urol. Focus (2023)] (European Urology Focus (2023) 9(6) (1052–1058), (S2405456923001232), (10.1016/j.euf.2023.05.012)) Other Scholarly Work

Linehan, J, Gottlieb, J, Woldu, SL et al. (2024). Corrigendum to “Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes” [Eur. Urol. Focus (2023)] (European Urology Focus (2023) 9(6) (1052–1058), (S2405456923001232), (10.1016/j.euf.2023.05.012)) . 10(1), 211. 10.1016/j.euf.2023.08.006

cited authors

  • Linehan, J; Gottlieb, J; Woldu, SL; Labbate, C; Rose, K; Sexton, W; Kaimakliotis, H; Jacob, J; Dickstein, R; Nieder, A; Bjurlin, M; Humphreys, M; Ghodoussipour, S; Quek, M; O'Donnell, M; Eisner, BH; Feldman, AS; Matin, SF; Lotan, Y; Murray, KS

authors

abstract

  • The authors regret, that there were 2 missed corrections on the final proof. The corresponding author, Josh Gottlieb, was incorrectly listed to have affiliation “b” for University of Texas Southwestern Medical Center. Josh Gottlieb's correct affiliation should be the same as the first author, Jennifer Linehan (Providence Specialty Medical Group). In addition, Dr. Saum Ghodoussipour (correct spelling) was spelled incorrectly as Ghodoussipor (incorrect spelling) on the final proof. The corrections are updated as above. The authors would like to apologise for any inconvenience caused.

publication date

  • January 1, 2024

Digital Object Identifier (DOI)

start page

  • 211

volume

  • 10

issue

  • 1